• Explore /
  • Poster
  • / Association of morphologic response with progression free survival in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy: HGCSG0802.

Association of morphologic response with progression free survival in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy: HGCSG0802.

Abstract Poster

Authors

Satoshi Yuki

Satoshi Yuki

Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan

Satoshi Yuki , Hiroshi Nakatsumi , Hideyuki Hayashi , Hiraku Fukushima , Takashi Kato , Takashi Meguro , Michio Nakamura , Ichiro Iwanaga , Kazunori Eto , Atsushi Sato , Hiroyuki Okuda , Ayane Oba , Takuto Miyagishima , Osamu Muto , Satoshi Yabusaki , Noriyuki Miyamoto , Kohsuke Kudo , Naoya Sakamoto , Yuh Sakata , Yoshito Komatsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 743)

DOI

10.1200/jco.2015.33.3_suppl.743

Abstract #

743

Poster Bd #

E33

Abstract Disclosures

Similar Posters

First Author: David Malka

First Author: Everardo D. Saad

First Author: Stefan Kubicka

First Author: Alessandro Passardi